BioLife Solutions, Inc. (BLFS)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in BioLife Solutions, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

BioLife Solutions, Inc. (BLFS) has returned -21.09% so far this year and -16.46% over the past 12 months. Looking at the last ten years, BLFS has achieved an annualized return of 26.42%, outperforming the S&P 500 Index benchmark, which averaged 12.16% per year.

Based on dividend-adjusted daily data since May 26, 1992, BLFS's average daily return is +0.60%, while the average monthly return is +3.84%. At this rate, your investment would double in approximately 1.5 years.

Historically, 43% of months were positive and 57% were negative. The best month was Jun 2000 with a return of +463.3%, while the worst month was Oct 2000 at -56.0%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 8 months.

On a daily basis, BLFS closed higher 35% of trading days. The best single day was Jun 16, 2000 with a return of +358.5%, while the worst single day was Oct 12, 2011 at -71.4%.

BioLife Solutions, Inc. has an annualized alpha of 335.14%, beta of 0.46, and R² of 0.00 versus S&P 500 Index. Calculated based on daily prices since May 27, 1992.

• This stock participated in 116.64% of S&P 500 Index downside but only 53.16% of its upside — more exposed to losses than it benefited from rallies.
• Beta of 0.46 may look defensive, but with R² of 0.00 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R² of 0.00 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

BLFS ranks 19 for risk / return — in the bottom 19% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The table below present risk-adjusted performance metrics for BioLife Solutions, Inc. (BLFS) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the BioLife Solutions, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the BioLife Solutions, Inc. was 99.80%, occurring on Oct 15, 2008. The portfolio has not yet recovered.

The current BioLife Solutions, Inc. drawdown is 86.37%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of BioLife Solutions, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how BioLife Solutions, Inc. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.